Yang Yun, Guo Lengqiu, Yu Jinghua, Peng Wei, Wang Qi, Wei Lan, Chen Xihua, Min Chunyan, Jiang Xiaogang, Zhu Song, Zhao Haixin, Xuan Zhenyu, Yu Jianzhong, Zhang Jian
College of Pharmaceutical Science, Soochow University, Suzhou, China.
Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Vocational Health College, Suzhou, China.
Ann Med. 2025 Dec;57(1):2519684. doi: 10.1080/07853890.2025.2519684. Epub 2025 Jun 18.
Da-Yuan-Yin Decoction (DYY), used since the early Qing Dynasty in China for damp-heat syndrome, was evaluated for its comprehensive protective effects.
Rats received a high-fat/high-sugar diet for 14 days, then daily exposure to high temperature/humidity (31.0 ± 0.5°C, 85%-95%) for 10 hours over 14 days. Damp-heat syndrome was induced on day 29 via intraperitoneal lipopolysaccharide (LPS) injections (1 mg/kg and 0.5 mg/kg after 4 hours). Two hours post-modeling, rats received DYY (400 or 800 mg/kg/day) orally for 5 days. Symptoms were scored. On day 33, kidney, spleen, tongue, lung, liver, stomach, and colon tissues underwent histopathological and immunochemical/immunofluorescence analysis. Serum levels of inflammation factors, C-reactive protein (CRP), cell-free DNA (cfDNA), myeloperoxidase (MPO), and superoxide dismutase (SOD) were quantified. Complete blood count (CBC), blood biochemistry, short-chain fatty acids (SCFAs), gut microbiota composition in the colon, and metabolites in the cecum were analyzed.
DYY significantly reduced symptom scores and decreased CRP level, while also regulating parameters in CBC and biochemical profiles. The treatment ameliorated tissue damage in the kidney, spleen, tongue, lung, liver, stomach, and colon. DYY downregulated citrullinated histone H3 (Cit H3), polyclonal peptidylarginine deiminase 4 (PADI4), and MPO expressions in the lung, stomach, and colon. Furthermore, it modulated inflammatory responses, suppressed the interleukin-23 (IL-23)/janus kinase-2 (JAK2)/signal transduction and transcription activator-3 (STAT3) signaling pathway and enhanced antioxidant activity. DYY administration significantly increased total SCFA content. The intervention restored gut microbiota diversity and abundance, while ameliorating metabolic dysregulation.
Systemic pathophysiological alterations were observed in rats with damp-heat syndrome. The comprehensive protective effects of DYY involved suppression of neutrophil extracellular traps (NETs) formation through downregulation of PADI4 expression, modulation of inflammatory responses, inhibition of the IL-23/JAK2/STAT3 signaling pathway, restoration of intestinal microecological balance and metabolic homeostasis, and enhancement of antioxidant.
大元饮汤(DYY)自清朝初期在中国就被用于治疗湿热证,本研究对其综合保护作用进行了评估。
大鼠先接受14天的高脂/高糖饮食,然后在14天内每天暴露于高温/高湿环境(31.0±0.5°C,85%-95%)10小时。在第29天通过腹腔注射脂多糖(LPS)(4小时后分别注射1mg/kg和0.5mg/kg)诱导湿热证。造模后2小时,大鼠口服DYY(400或800mg/kg/天),持续5天。对症状进行评分。在第33天,对肾脏、脾脏、舌头、肺、肝脏、胃和结肠组织进行组织病理学和免疫化学/免疫荧光分析。对血清中的炎症因子、C反应蛋白(CRP)、游离DNA(cfDNA)、髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)水平进行定量分析。分析全血细胞计数(CBC)、血液生化、短链脂肪酸(SCFAs)、结肠中的肠道微生物群组成以及盲肠中的代谢产物。
DYY显著降低症状评分并降低CRP水平,同时还调节了CBC和生化指标中的参数。该治疗改善了肾脏、脾脏、舌头、肺、肝脏、胃和结肠的组织损伤。DYY下调了肺、胃和结肠中瓜氨酸化组蛋白H3(Cit H3)、多克隆肽基精氨酸脱亚氨酶4(PADI4)和MPO的表达。此外,它调节炎症反应,抑制白细胞介素-23(IL-23)/Janus激酶-2(JAK2)/信号转导和转录激活因子-3(STAT3)信号通路并增强抗氧化活性。给予DYY显著增加了总SCFA含量。该干预恢复了肠道微生物群的多样性和丰度,同时改善了代谢失调。
在湿热证大鼠中观察到了全身病理生理改变。DYY的综合保护作用包括通过下调PADI4表达抑制中性粒细胞胞外陷阱(NETs)形成、调节炎症反应、抑制IL-23/JAK2/STAT3信号通路、恢复肠道微生态平衡和代谢稳态以及增强抗氧化作用。